Stress-hormone signalling protects spreading cancer cells from immune system
Article Date: 04 March 2026
Article URL: https://www.nature.com/articles/d41586-026-00650-5
Article Image: https://media.nature.com/lw100/magazine-assets/d41586-026-00650-5/d41586-026-00650-5_52135150.jpg
Summary
Metastasis — the spread of cancer cells to new organs — requires those cells to survive encounters with the immune system. New analysis shows that tumour cells co-opt stress-hormone signalling via the glucocorticoid receptor (GR) to evade immune killing during the early steps of metastatic seeding. The work identifies a glucocorticoid–FAS axis that helps disseminating cells resist immune-cell attack and points to GR signalling as a potential target to block metastasis.
Key Points
- Disseminating cancer cells activate stress-hormone signalling through the glucocorticoid receptor (GR) to avoid immune-mediated elimination during metastatic seeding.
- A glucocorticoid–FAS axis was identified as a mechanism by which tumour cells reduce susceptibility to killing by immune cells.
- Evidence comes from analysis of human tumours and experimental models showing upregulation of GR-related programmes at the seeding stage.
- Targeting GR signalling or components of the FAS-related pathway could be a therapeutic strategy to reduce metastatic spread.
- Findings connect systemic stress signals (and possibly clinical glucocorticoid use) with biological programmes that enhance metastatic survival.
Context and relevance
This research briefing summarises a Nature paper that links neuroendocrine stress signalling to a concrete molecular mechanism of immune evasion during metastasis. It matters because metastasis — not the primary tumour — is the main cause of cancer mortality, and mechanisms that let circulating cells survive immune attack are prime targets for intervention. The work sits at the intersection of cancer biology, immunology and stress endocrinology and could influence how we think about peri-operative care, steroid use and drug development aimed at preventing metastasis.
Why should I read this?
Want the short version? Tumour cells hijack your body’s stress signals to hide from immune cells while they spread — and researchers have pinned down a GR–FAS axis that does the dirty work. If you’re into cancer research, drug targets, or the effects of stress and steroids on disease, this is a neat, actionable lead worth checking out.